U.S. drug shortages for medications used in adult critical care (2001–2016)

Journal of Critical Care

Volumn 41, Issue , 2017, Pages 283-288

  Mazer Amirshahi, Maryann ^a,b   Goyal, Munish ^a,b   Umar, Suleman A ^a   Fox, Erin R ^c   Zocchi, Mark ^d   Hawley, Kristy L ^e   Pines, Jesse M ^d,f  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e UNION MEMORIAL HOSPITAL   (United States)

^f GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Critical care; Drug shortages

Indexed keywords

AMINO ACID; AMIODARONE; ANTIBIOTIC AGENT; CALCIUM CHLORIDE; CISATRACURIUM; DOBUTAMINE; DOPAMINE; EPINEPHRINE; GLYCERYL TRINITRATE; LORAZEPAM; NORADRENALIN; PIPERACILLIN PLUS TAZOBACTAM; PROPOFOL; VECURONIUM; PRESCRIPTION DRUG;

ADULT; ADULTHOOD; ARTICLE; DRUG SHORTAGE; DRUG USE; HUMAN; INFECTION; INTENSIVE CARE; RESOURCE MANAGEMENT; UNITED STATES; DRUG SUBSTITUTION; HOSPITAL EMERGENCY SERVICE; HOSPITAL PHARMACY; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; UTAH; UTILIZATION;

CRITICAL CARE; DRUG SUBSTITUTION; EMERGENCY SERVICE, HOSPITAL; HUMANS; PHARMACY SERVICE, HOSPITAL; PRESCRIPTION DRUGS; UTAH;

EID: 85029688265     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2017.06.005     Document Type: Article

References (27)

1. Fox, E.R.S.B., Jensen, V., Drug shortages: a complex health care crisis. Mayo Clin Proc 89:3 (2014), 361–373.
2. FDA Center for Drug Evaluation and Research FaDA, Manual of policies and procedures (MAPP): drug shortage management. 4190, 2014, Food and Drug Administration.
3. National Drug Shortages, http://www.ashp.org/DocLibrary/Policy/DrugShortages/OPA-National-Drug-Shortages.
4. (GAO) USGAO, Drug shortages public health threat continues, despite efforts to help ensure product availability. Report to congressional addressees, 2014 (http://www.gao.gov/assets/670/660785.pdf).
5. (GAO) USGAO, Drug shortages: certain factors are strongly associated with this persistent public health challenge. http://www.gao.gov/products/GAO-16-595, 2016.
6. McLaughlin, M., Kotis, D., Thomson, K., Harrison, M., Fennessy, G., Postelnick, M., et al. Effects on patient care caused by drug shortages: a survey. J Manag Care Pharm 19:9 (2013), 783–788.
7. Fox, E.R., Tyler, L.S., Potential association between drug shortages and high-cost medications. Pharmacotherapy 37:1 (2017), 36–42.
8. Ventola, C.L., The drug shortage crisis in the United States: causes, impact, and management strategies. P T 36:11 (2011), 740–757.
9. Hicks, R.W.B.S., An overview of intravenous-related medication administration errors as reported to MEDMARX, a national medication error-reporting program. J Infus Nurs 29:1 (2006), 20–27.
10. ISMP, Drug shortages: national survey reveals high level of frustration, low level of safety. ISMP medication safety alert!, 15, 2010.
11. Chen, S.I.F.E., Hall, M.K., Ross, S.J., Bucholz, E.M., Krumholz, H.M., Venkatesh, A.K., Despite federal legislation, shortages of drugs used in acute care settings remain persistent and prolonged. Health Aff 35:5 (2016), 798–804.
12. Fox, E., Tyler, L., Managing drug shortages: seven years’ experience at one health system. Am J Health Syst Pharm 60:3 (2003), 245–253.
13. Mazer-Amirshahi, M., Hawley, K.L., Zocchi, M., Fox, E., Pines, J.M., Nelson, L.S., Drug shortages: implications for medical toxicology. Clin Toxicol (Phila) 53:6 (2015), 519–524.
14. Mazer-Amirshahi, M., Pourmand, A., Singer, S., Pines, J.M., van den Anker, J., Critical drug shortages: implications for emergency medicine. Acad Emerg Med 21:6 (2014), 704–711.
15. Cochrane, D.O.G., Application of least squares regression to relationships containing auto-correlated error terms. J Am Stat Assoc 44:245 (1949), 32–61.
16. Hawley, K.L.M.-A.M., Zocchi, M.S., Fox, E.R., Pines, J.M., Longitudinal trends in U.S. drug shortages for medications used in emergency departments (2001–2014). Acad Emerg Med 23:1 (2015), 63–69.
17. Health Policy Brief, Drug shortages. Government and private-sector leaders have struggled to address persistent drug shortages driven by complex market forces. http://healthaffairs.org/healthpolicybriefs/brief_pdfs/healthpolicybrief_124.pdf.
18. Economic analysis of the causes of drug shortages. ASPE issue brief. http://aspe.hhs.gov/sp/reports/2011/DrugShortages/ib.pdf.
19. U.S. House of Representatives Committee on Oversight and Government Reform, FDA's contribution to the drug shortage crisis. In. edited by Reform CoOaG. 2012.
20. FDA Safety and Innovation Act (FDASIA) title X. In. Edited by Administration USFaD: U.S. Government Publishing Office, 2012.
21. Strategic plan for mitigating and preventing drug shortages. (In. Edited by), 2013, Administration USFaD.
22. Solomkin, J.S.M.J., Bradley, J.S., Rodvold, K.A., Goldstein, E.J.C., Baron, E.J., O'Neill, P.J., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50:2 (2010), 133–164.
23. Kumar, A., Roberts, D., Wood, K.E., Light, B., Parrillo, J.E., Sharma, S., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.[see comment]. Crit Care Med 34:6 (2006), 1589–1596.
24. Arrigo, M.B.D., Rudiger, A., Management of atrial fibrillation in critically ill patients. Crit Care Res Prac, 2014, 2014, 10.
25. Vail, E.G.H., Hua, M., Walkey, A.J., Rubenfeld, G., Wunsch, H., Association between U.S. norepinephrine shortage and mortality among patients with septic shock. JAMA 317:14 (2017), 1433–1442.
26. Barr, J.F.G., Puntillo, K., Ely, E.W., Gélinas, C., Dasta, J.F., Davidson, J.E., et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41:1 (2013), 263–306.
27. Rosoff, P.M., Unpredictable drug shortages: an ethical framework for short-term rationing in hospitals. Am J Bioeth 12:1 (2012), 1–9.